Delivery Order SPE2DB20D3103-SPE2DB25FP6K2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,052.95 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used by military service members and veterans through the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.27 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within...
- The Defense Logistics Agency awarded a delivery order valued at $4,765.67 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used primarily for managing...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $14,137.08. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a medication...
- The Defense Logistics Agency awarded a delivery order valued at $21,234.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90-count packages. This competitive award, valued at $6,795.94, carries a firm fixed price structure with an ultimate completion date of August 8, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and...
- The Defense Logistics Agency awarded a $2,906.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-competitive delivery order was fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. The place of performance is...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6K2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,392.64 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and is being fulfilled from the contractor's place of business in Conshohocken, Pennsylvania. Jardiance is a prescription medication used to manage type 2 diabetes, reflecting the federal government's ongoing pharmaceutical supply needs for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical supply requirements through competitive procurement processes and firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/25/25 |